Our research showed that serum DJ-1 was significantly higher in 172 patients with BC who underwent the transurethral resection of bladder tumors (TURBT) than in those with urolithiasis or in healthy participants. This evidence concerns the gene PARK7 and urinary bladder neoplasm.